粒细胞巨噬细胞集落刺激因子抑制氟尿嘧啶诱导的胃癌细胞凋亡增强耐药性的实验研究

doi:10.3877/cma.j.issn.1674-0793.2020.01.004

中华普通外科学文献(电子版) ›› 2020, Vol. 14 ›› Issue (01) : 10 -13. doi: 10.3877/cma.j.issn.1674-0793.2020.01.004

所属专题：文献；

论著

粒细胞巨噬细胞集落刺激因子抑制氟尿嘧啶诱导的胃癌细胞凋亡增强耐药性的实验研究

常仕林¹, 何进鹏², 陈亚琼³, 蔡辉⁴^,^†(

)

^1. 750004　银川，宁夏医科大学
^2. 730013　兰州，中国科学院兰州分院空间辐射生物学实验室
^3. 730013　兰州，甘肃省人民医院医务处
^4. 730013　兰州，甘肃省人民医院普外科

收稿日期:2019-08-19 出版日期:2020-02-01
通信作者: 蔡辉

Granulocyte macrophage colony stimulating factor enhancing drug resistance of gastric cancer cells by inhibiting apoptosis

Shilin Chang¹, Jinpeng He², Yaqiong Chen³, Hui Cai⁴^,^†()

^1. Ningxia Medical University, Yinchuan 750004, China
^2. Laboratory of Space Radiation Biology, Lanzhou Branch of Chinese Academy ofSciences, Lanzhou 730013, China
^3. Medical Office, Gansu Provincial People’s Hospital, Lanzhou 730013, China
^4. Department of General Surgery, Gansu Provincial People’s Hospital, Lanzhou 730013, China

Received:2019-08-19 Published:2020-02-01
Corresponding author: Hui Cai
About author:
Corresponding author: Cai Hui, Email: caialonteam@163.com

全文 ( ) 下载PDF ( ) 导出引用

目的

通过检测粒细胞巨噬细胞集落刺激因子（GM-CSF）对氟尿嘧啶（5-FU）诱导后胃癌细胞凋亡的影响，初步探讨GM-CSF参与胃癌细胞耐药性的相关机制。

方法

体外培养胃癌SGC7901细胞，MTT法检测5-FU作用于胃癌细胞的半致死剂量；将GM-CSF添加到5-FU处理的胃癌细胞中，MTT法和平板克隆实验检测其对细胞活性和克隆增殖的影响，Annexin V-FITC/PI双染法流式细胞术检测细胞凋亡情况。Western blotting检测凋亡相关蛋白Bax和Bcl-2的表达差异。

结果

5-FU对胃癌细胞的半致死剂量为（16±0.4）mg/L。5-FU对胃癌细胞的活性和增殖能力有明显的抑制作用，GM-CSF能有效减弱5-FU的抑制效果（P<0.05）。5-FU能显著诱导胃癌细胞凋亡，Bax/Bcl-2比值显著升高，而加入GM-CSF后，5-FU诱导的凋亡被抵抗，Bax/Bcl-2比值升高趋势被抑制（P<0.05）。

结论

GM-CSF能够促进胃癌细胞增殖并有效抑制5-FU诱导的胃癌细胞凋亡，在增强胃癌细胞化疗耐药性方面具有重要作用。

关键词: 粒细胞巨噬细胞集落刺激因子, 胃肿瘤, 细胞凋亡, 抗药性,肿瘤, 氟尿嘧啶

Objective

By detecting the effects of granulocyte macrophage colony stimulating factor (GM-CSF) on the apoptosis of gastric cancer cells induced by fluorouracil (5-FU), the mechanism of GM-CSFinvolved in drug resistance of gastric cancer cells was preliminarily explored.

Methods

The gastric cancer SGC7901 cells were cultured in vitro, and the semi-lethal dose of 5-FU on gastric cancer cells was detected by MTT assay. GM-CSF was added to 5-FU-treated gastric cancer cells. The effects of cell proliferation and clonal proliferation were detected by MTT and plate cloning assay. Apoptosis was detected by Annexin V-FITC/PI flow cytometry. Western blotting was used to detect the expression differences of apoptosis-related proteins Bax and Bcl-2.

Results

The semi-lethal dose of 5-FU to gastric cancer cells was (16±0.4) mg/L.5-FU could inhibit the activity and proliferation of gastric cancer cells, which could be effectively weakened by GM-CSF (P<0.05). 5-FU induced apoptosis of gastric cancer cells significantly, Bax/Bcl-2 ratio was significantly increased, while GM-CSF could reverse these trend (P<0.05).

Conclusion

GM-CSF can promote the proliferation of gastric cancer cells and effectively inhibit the apoptosis of gastric cancer cells induced by 5-FU, and plays an important role in enhancing the chemoresistance of gastric cancer cells.

Key words: Granulocyte-macrophage colony-stimulating factor, Stomach neoplasms, Apoptosis, Drug resistance, neoplasm, Fluorouracil

图2 不同处理方式对胃癌SGC7901细胞活性和细胞增殖的影响　A为MTT法检测各组细胞活性率结果，与对照组相比，*P<0.05；联合组与5-FU诱导组相比，*P<0.05。B为克隆形成率，与对照组相比，*P<0.05，**P<0.01；联合组与5-FU诱导组相比，*P<0.05。C为平板克隆实验结果图片；a为空白对照组；b为GM-CSF刺激组；c为5-FU诱导组；d为联合组

图3 倒置相差显微镜下观察四组细胞凋亡情况

图4 不同处理方式对胃癌SGC7901细胞凋亡影响的结果　A为Annexin-V检测细胞凋亡结果；B为四组细胞凋亡率比较，与对照组比较，*P<0.05；联合组与5-FU诱导组相比，*P<0.05

图5 不同处理方式对胃癌SGC7901细胞Bax、Bcl-2蛋白表达的影响　A为各组Bax、Bcl-2蛋白表达结果；B为各组Bax/Bcl-2比值结果；与对照组相比，*P<0.05；联合组与5-FU诱导组相比，*P<0.05

[1]	Nantajit D, Lin D, Li JJ. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance[J]. J Cancer Res Clin Oncol, 2015, 141(10): 1697-1713.
[2]	Metcalf D. The colony-stimulating factors and cancer[J]. Nat Rev Cancer, 2010, 10(6): 425-434.
[3]	Thorn M, Guha P, Cunetta M, et al. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases[J]. Cancer Gene Ther, 2016, 23(6): 188-198.
[4]	Liu Q, Qiao L, Hu P, et al. The effect of granulocyte and granulocyte-macrophage colony stimulating factors on tumor promotion[J]. J BUON, 2017, 22(1): 21-28.
[5]	Aliper AM, Frieden-Korovkina VP, Buzdin A, et al. A role for G-CSF and GM-CSF in nonmyeloid cancers[J]. Cancer Med, 2014, 3(4): 737-746.
[6]	Vilalta M, Brune J, Rafat M, et al. The role of granulocyte macrophage colony stimulating factor (GM-CSF) in radiation-induced tumor cell migration[J]. Clin Exp Metastasis, 2018, 35(4): 247-254.
[7]	丁欣. KRAS突变型结肠癌化疗耐药的新机制[D]. 合肥：安徽医科大学, 2018.
[8]	Janik JE, Miller LL, Korn EL, et al. A prospective randomized phase trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma[J]. Blood, 2001, 97(7): 1942-1946.
[9]	Thongprasert S. Phase study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer[J]. J Med Assoc Thai, 2000, 83(5): 549-553.
[10]	Charrier S, Chollet P, Bay JO, et al. Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer[J]. Bone Marrow Transplant, 2000, 25(7): 705-710.
[11]	Hong IS. Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types[J]. Exp Mol Med, 2016, 48(7): e242.
[12]	王一. 粒细胞-巨噬细胞集落刺激因子（GM-CSF）和白介素（IL）-1β在慢性肠炎恶性转化中的作用及机制研究[D]. 北京：中国人民解放军军事医学科学院, 2014.
[13]	Xie Q, Wu MY, Zhang DX, et al. Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo[J]. World J Gastroenterol, 2016, 22(32): 7342-7352.
[14]	Revoltella RP, Menicagli M, Campani D. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas[J]. Cytokine, 2012, 57(3): 347-359.
[15]	Wang H, Li H, Chen F, et al. Baicalin extracted from Huangqin (Radix Scutellariae Baicalensis) induces apoptosis in gastric cancer cells by regulating B cell lymphoma(Bcl-2)/Bcl-2-associated X protein and activating caspase-3 and caspase-9[J]. J Tradit Chin Med, 2017, 37(2): 229-225.
[16]	Ye W, Li Y, Fan L, et al. Effect of annexin A7 suppression on the apoptosis of gastric cancer cells[J]. Mol Cell Biochem, 2017, 429(1-2): 33-43.

[1]	安杰, 牛云峰, 刘伟. LINC00520 通过miR-519b-3p/HIF1A 轴促进胃癌的侵袭转移[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 430-436.
[2]	李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3]	陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4]	许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5]	李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6]	刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7]	任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8]	王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[9]	陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[10]	贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[11]	梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[12]	刘海旺, 施海, 尚利峰. 不同吻合器在腹腔镜远端胃癌根治术Roux-en-Y式吻合中的应用对比[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 643-646.
[13]	许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[14]	黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[15]	张立俊, 孙存杰, 胡春峰, 孟冲, 张辉. MSCT、DCE-MRI 评估术前胃癌TNM 分期的准确性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 519-523.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Granulocyte macrophage colony stimulating factor enhancing drug resistance of gastric cancer cells by inhibiting apoptosis

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Granulocyte macrophage colony stimulating factor enhancing drug resistance of gastric cancer cells by inhibiting apoptosis